Genesis Growth Tech Acquisition Corporation (GGAAU) Quote

Completely agree with you. What is he waiting for? Why hold it down?

Keep repeating your “kick the can” slogan, son. Or you could do your job and come up with something original that requires actual thought.

Address Updated:
🔴 208 East 51 Street, Suite 112, New York, NY, 10022, United States
🟢 1159 2nd Avenue, Ste 454, New York, NY, 10065, United States

Hey this is a "Mom and Dad send money!" message I used to send my parents when I was in college. and I had no money at the end of the month.
BTW they never did...But it was worth a try.

LC

WDRP

https://finance.yahoo.com/news/49-ownership-skeena-resources-limited-112245162.html

You want me to list the very long list of NSAV red flags? 🤣🤣🤣 NSAV has scam written all over it, led by the three in management,

Good call Dan…as that’s exactly what happened…there was actually a negative surge in the Bay…the water got sucked out by the circular wind from the north.

https://www.fool.com/investing/2024/10/08/why-energy-transfer-is-my-top-investment-for-passi/

My suspicion level is slowly rising that the silk may not be of sufficient quality
I had that same thought recently. It's possible that the silk that coming out of Bam-1 worms may be only slightly better than traditional silk. All we know is that they seem to be scaling up the production of s

Jarred had been working the projects for years, so when he took over he could hit the ground running.

Your spill is a lie, just an outright lie.

“Has to be the most bizarre stream of consciousness or unconsciousness I’ve ever seen.”
I’d say that describes your ramblings perfectly.
Kudos on your level of self-awareness.
So rare on these boards…

In 2024, Revance Therapeutics (RVNC) faced substantial costs and operating expenses to support the revenues from Daxxify and the RHA Collection. For the year, RVNC projected total GAAP operating expenses between $430 million and $460 million. These expenses encompass research and development (R&D),

SIPC up 10%. Bull's running!

LC

SIPC

SIPC up 10%. Bull's running!

LC

SIPC

Gary,

What kind of approval will come from UK? DCVAX-L + Poly-ICLC

Should DCVAX-L deserve Platform Technology Designation from FDA?

Why would a small company like Oncovir keep secret for partnerships?

Don't treat this DCVAX-L as a singular

TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today reported its second quarter (Q2) and half year (H1) results for the period ended June 30th, 2024.
https://www.globenewswire.com/en/news-release/2024/08/07/2926501/37420/en/McEwen-Mining-Q2-2024-Results.

This should be stickied

Gitreal has personally cost me major bucks because he drove folks out of stocks that went up eventually,

But also by driving stocks out of business, keeping them from raising sufficient funding.

He has cost folks millions over the

Dont like GTSM parking at .0009 ask with 10k showing though.
But yes all buys today and best volume in a month.

Hey Ben! Don't be a rat. Be cool, and don'r ya' think it's time to get this NFT thing goin'!
Thank you for you due consideration.

L'il 'ol Lambchops.

NFTM

Having a laugh. A pretty good one at that

So are trips.
Oh wait-

Waiting for this piece of filth stock to do something !!!!!

I’ve owned gncp for 14 years and nothing ever happens

It’s like a fake company to pay management salaries and dilute shares to pay them !!!!

A kid lemonade stand makes more in a day than gncp h

LOL. Team CCL for a win. Yes, trippininLaCoste, you started with a nice lead off double, then a walk, a single by TESLIN, then the big home run call by chris3403 !!! CCL wins !!!

CCL longs win !!!

All sells today,hopefully flippers are out.Like to see buying to close out the week on a high note.

Revance Therapeutics (RVNC) generated significant revenue from both Daxxify and its partnership with Teoxane’s RHA product line in 2024. In Q2 2024, revenue from Daxxify, primarily in the aesthetics segment, grew by 27% year-over-year, reaching $28.7 million. Additionally, the RHA Collection, which